SendFriend Next Generation Remittance Company Announces $1.7M in Capital from 8 Decimal Capital, Techstars, 2020 Ventures, Barclays, MIT Media Lab
February 11, 2019 09:00 ET
|
SendFriend
New York, Feb. 11, 2019 (GLOBE NEWSWIRE) -- SendFriend, the next-generation remittance service and currently, the smartest way to send money to the Philippines, today announced it has raised $1.7M...
Gate Ventures PLC raises USD 2 million
October 25, 2018 10:29 ET
|
Gate Ventures Plc
Gate Ventures PLCGate Ventures PLC Raises USD 2 millionISIN Number: GB00BYX2WP92TICKER: GATEPress Release Thursday, October 25, 2018 Gate Ventures PLC("Gate Ventures" or "Gate" or...
Food For The Poor Canada Donors Give Generously Towards Building a Village in Haiti
October 16, 2018 06:00 ET
|
Food For The Poor Of Canada Inc
TORONTO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- A small village in Haiti will have hope renewed when poverty begins to recede, through the development of agricultural projects, the building of homes and...
Update: Fundraising: Gate Ventures receives signed subscription letter for £2.5m
September 14, 2018 13:13 ET
|
Gate Ventures Plc
Gate Ventures PLCUpdate regarding subscription of sharesISIN Number: GB00BYX2WP92TICKER: GATEGate Ventures PLCPress Release ...
Gate Ventures PLC: Announcement regarding subscription of shares
July 04, 2018 14:03 ET
|
Gate Ventures Plc
Gate Ventures PLCAnnouncement regarding subscription of sharesISIN Number: GB00BYX2WP92TICKER: GATEGate Ventures PLCPress Release July 4, 2018 Gate Ventures PLC("Gate Ventures" or...
iTeos Therapeutics Completes $75 Million Series B Financing
June 20, 2018 07:00 ET
|
iTeos Therapeutics SA
iTeos Therapeutics Completes $75 Million Series B Financing Oversubscribed financing round led by new U.S. investor MPM Capital Proceeds to support accelerated development of innovative...
iTeos Therapeutics Completes $75 Million Series B Financing
June 20, 2018 01:00 ET
|
iTeos Therapeutics SA
iTeos Therapeutics Completes $75 Million Series B Financing Oversubscribed financing round led by new U.S. investor MPM Capital Proceeds to support accelerated development of innovative...
TRiCares réalise une Série B de €22 Millions ($25.4 Millions) pour le développement de son traitement mini-invasif de la régurgitation tricuspide
June 04, 2018 02:00 ET
|
TRiCares SAS
TRiCares réalise une Série B de €22 Millions ($25.4 Millions) pour le développement de son traitement mini-invasif de la régurgitation tricuspide Paris (France) et Munich (Allemagne), 4 juin 2018 -...
TRiCares schließt eine Finanzierungsrunde der Serie B in Höhe von € 22 Millionen ($ 25,4 Millionen) zur Investition in die Entwicklung einer minimal invasiven Behandlung von Trikuspidal-Insuffizienz
June 04, 2018 02:00 ET
|
TRiCares SAS
TRiCares schließt eine Finanzierungsrunde der Serie B in Höhe von € 22 Millionen ($ 25,4 Millionen) zur Investition in die Entwicklung einer minimal invasiven Behandlung von Trikuspidal-Insuffizienz ...
TRiCares Closes €22 Million ($25.4 Million) Series B Financing Round to Fund Development of Minimally Invasive Treatment of Tricuspid Regurgitation
June 04, 2018 02:00 ET
|
TRiCares SAS
TRiCares Closes €22 Million ($25.4 Million) Series B Financing Round to Fund Development of Minimally Invasive Treatment of Tricuspid Regurgitation Paris, France and Munich, Germany, June 4, 2018 -...